Pharma & Healthcare
Global Transdermal Patch Market Research Report 2025
- Mar 11, 25
- ID: 30648
- Pages: 105
- Figures: 98
- Views: 13
The global market for Transdermal Patch was valued at US$ 7287 million in the year 2024 and is projected to reach a revised size of US$ 9302 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Patch.
The Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transdermal Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Segment by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segment by Application
Rx Channel
OTC Channel
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transdermal Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Patch.
The Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transdermal Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Segment by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segment by Application
Rx Channel
OTC Channel
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transdermal Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Transdermal Patch Market Overview
1.1 Product Definition
1.2 Transdermal Patch by Type
1.2.1 Global Transdermal Patch Market Value Comparison by Type (2024 VS 2031)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Transdermal Patch by Application
1.3.1 Global Transdermal Patch Market Value by Application (2024 VS 2031)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Global Transdermal Patch Market Size Estimates and Forecasts
1.4.1 Global Transdermal Patch Revenue 2020-2031
1.4.2 Global Transdermal Patch Sales 2020-2031
1.4.3 Global Transdermal Patch Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Transdermal Patch Market Competition by Manufacturers
2.1 Global Transdermal Patch Sales Market Share by Manufacturers (2020-2025)
2.2 Global Transdermal Patch Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Transdermal Patch Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Transdermal Patch, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transdermal Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal Patch, Product Type & Application
2.7 Global Key Manufacturers of Transdermal Patch, Date of Enter into This Industry
2.8 Global Transdermal Patch Market Competitive Situation and Trends
2.8.1 Global Transdermal Patch Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Transdermal Patch Players Market Share by Revenue
2.8.3 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Transdermal Patch Market Scenario by Region
3.1 Global Transdermal Patch Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Transdermal Patch Sales by Region: 2020-2031
3.2.1 Global Transdermal Patch Sales by Region: 2020-2025
3.2.2 Global Transdermal Patch Sales by Region: 2026-2031
3.3 Global Transdermal Patch Revenue by Region: 2020-2031
3.3.1 Global Transdermal Patch Revenue by Region: 2020-2025
3.3.2 Global Transdermal Patch Revenue by Region: 2026-2031
3.4 North America Transdermal Patch Market Facts & Figures by Country
3.4.1 North America Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Transdermal Patch Sales by Country (2020-2031)
3.4.3 North America Transdermal Patch Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transdermal Patch Market Facts & Figures by Country
3.5.1 Europe Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Transdermal Patch Sales by Country (2020-2031)
3.5.3 Europe Transdermal Patch Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal Patch Market Facts & Figures by Region
3.6.1 Asia Pacific Transdermal Patch Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Transdermal Patch Sales by Region (2020-2031)
3.6.3 Asia Pacific Transdermal Patch Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Transdermal Patch Market Facts & Figures by Country
3.7.1 Latin America Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Transdermal Patch Sales by Country (2020-2031)
3.7.3 Latin America Transdermal Patch Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Transdermal Patch Sales by Country (2020-2031)
3.8.3 Middle East and Africa Transdermal Patch Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transdermal Patch Sales by Type (2020-2031)
4.1.1 Global Transdermal Patch Sales by Type (2020-2025)
4.1.2 Global Transdermal Patch Sales by Type (2026-2031)
4.1.3 Global Transdermal Patch Sales Market Share by Type (2020-2031)
4.2 Global Transdermal Patch Revenue by Type (2020-2031)
4.2.1 Global Transdermal Patch Revenue by Type (2020-2025)
4.2.2 Global Transdermal Patch Revenue by Type (2026-2031)
4.2.3 Global Transdermal Patch Revenue Market Share by Type (2020-2031)
4.3 Global Transdermal Patch Price by Type (2020-2031)
5 Segment by Application
5.1 Global Transdermal Patch Sales by Application (2020-2031)
5.1.1 Global Transdermal Patch Sales by Application (2020-2025)
5.1.2 Global Transdermal Patch Sales by Application (2026-2031)
5.1.3 Global Transdermal Patch Sales Market Share by Application (2020-2031)
5.2 Global Transdermal Patch Revenue by Application (2020-2031)
5.2.1 Global Transdermal Patch Revenue by Application (2020-2025)
5.2.2 Global Transdermal Patch Revenue by Application (2026-2031)
5.2.3 Global Transdermal Patch Revenue Market Share by Application (2020-2031)
5.3 Global Transdermal Patch Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Company Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson & Johnson Transdermal Patch Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis Transdermal Patch Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 UCB Pharma
6.4.1 UCB Pharma Company Information
6.4.2 UCB Pharma Description and Business Overview
6.4.3 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.4.4 UCB Pharma Transdermal Patch Product Portfolio
6.4.5 UCB Pharma Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Company Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan Transdermal Patch Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Company Information
6.6.2 Teva Pharmaceutical Description and Business Overview
6.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharmaceutical Transdermal Patch Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.7 Nitto Denko
6.7.1 Nitto Denko Company Information
6.7.2 Nitto Denko Description and Business Overview
6.7.3 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Nitto Denko Transdermal Patch Product Portfolio
6.7.5 Nitto Denko Recent Developments/Updates
6.8 Grünenthal
6.8.1 Grünenthal Company Information
6.8.2 Grünenthal Description and Business Overview
6.8.3 Grünenthal Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Grünenthal Transdermal Patch Product Portfolio
6.8.5 Grünenthal Recent Developments/Updates
6.9 IBSA Group
6.9.1 IBSA Group Company Information
6.9.2 IBSA Group Description and Business Overview
6.9.3 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.9.4 IBSA Group Transdermal Patch Product Portfolio
6.9.5 IBSA Group Recent Developments/Updates
6.10 GSK
6.10.1 GSK Company Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GSK Transdermal Patch Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Luye Pharma Group
6.11.1 Luye Pharma Group Company Information
6.11.2 Luye Pharma Group Description and Business Overview
6.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Luye Pharma Group Transdermal Patch Product Portfolio
6.11.5 Luye Pharma Group Recent Developments/Updates
6.12 Pfizer
6.12.1 Pfizer Company Information
6.12.2 Pfizer Description and Business Overview
6.12.3 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Pfizer Transdermal Patch Product Portfolio
6.12.5 Pfizer Recent Developments/Updates
6.13 Chattem
6.13.1 Chattem Company Information
6.13.2 Chattem Description and Business Overview
6.13.3 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Chattem Transdermal Patch Product Portfolio
6.13.5 Chattem Recent Developments/Updates
6.14 Dr Reddy’s Laboratories
6.14.1 Dr Reddy’s Laboratories Company Information
6.14.2 Dr Reddy’s Laboratories Description and Business Overview
6.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Dr Reddy’s Laboratories Transdermal Patch Product Portfolio
6.14.5 Dr Reddy’s Laboratories Recent Developments/Updates
6.15 Bayer
6.15.1 Bayer Company Information
6.15.2 Bayer Description and Business Overview
6.15.3 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Bayer Transdermal Patch Product Portfolio
6.15.5 Bayer Recent Developments/Updates
6.16 Mundipharma
6.16.1 Mundipharma Company Information
6.16.2 Mundipharma Description and Business Overview
6.16.3 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Mundipharma Transdermal Patch Product Portfolio
6.16.5 Mundipharma Recent Developments/Updates
6.17 Endo International
6.17.1 Endo International Company Information
6.17.2 Endo International Description and Business Overview
6.17.3 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Endo International Transdermal Patch Product Portfolio
6.17.5 Endo International Recent Developments/Updates
6.18 Beijing Tide Pharmaceutical
6.18.1 Beijing Tide Pharmaceutical Company Information
6.18.2 Beijing Tide Pharmaceutical Description and Business Overview
6.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Portfolio
6.18.5 Beijing Tide Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal Patch Industry Chain Analysis
7.2 Transdermal Patch Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal Patch Production Mode & Process Analysis
7.4 Transdermal Patch Sales and Marketing
7.4.1 Transdermal Patch Sales Channels
7.4.2 Transdermal Patch Distributors
7.5 Transdermal Patch Customer Analysis
8 Transdermal Patch Market Dynamics
8.1 Transdermal Patch Industry Trends
8.2 Transdermal Patch Market Drivers
8.3 Transdermal Patch Market Challenges
8.4 Transdermal Patch Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Transdermal Patch by Type
1.2.1 Global Transdermal Patch Market Value Comparison by Type (2024 VS 2031)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Transdermal Patch by Application
1.3.1 Global Transdermal Patch Market Value by Application (2024 VS 2031)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Global Transdermal Patch Market Size Estimates and Forecasts
1.4.1 Global Transdermal Patch Revenue 2020-2031
1.4.2 Global Transdermal Patch Sales 2020-2031
1.4.3 Global Transdermal Patch Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Transdermal Patch Market Competition by Manufacturers
2.1 Global Transdermal Patch Sales Market Share by Manufacturers (2020-2025)
2.2 Global Transdermal Patch Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Transdermal Patch Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Transdermal Patch, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transdermal Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal Patch, Product Type & Application
2.7 Global Key Manufacturers of Transdermal Patch, Date of Enter into This Industry
2.8 Global Transdermal Patch Market Competitive Situation and Trends
2.8.1 Global Transdermal Patch Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Transdermal Patch Players Market Share by Revenue
2.8.3 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Transdermal Patch Market Scenario by Region
3.1 Global Transdermal Patch Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Transdermal Patch Sales by Region: 2020-2031
3.2.1 Global Transdermal Patch Sales by Region: 2020-2025
3.2.2 Global Transdermal Patch Sales by Region: 2026-2031
3.3 Global Transdermal Patch Revenue by Region: 2020-2031
3.3.1 Global Transdermal Patch Revenue by Region: 2020-2025
3.3.2 Global Transdermal Patch Revenue by Region: 2026-2031
3.4 North America Transdermal Patch Market Facts & Figures by Country
3.4.1 North America Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Transdermal Patch Sales by Country (2020-2031)
3.4.3 North America Transdermal Patch Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transdermal Patch Market Facts & Figures by Country
3.5.1 Europe Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Transdermal Patch Sales by Country (2020-2031)
3.5.3 Europe Transdermal Patch Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal Patch Market Facts & Figures by Region
3.6.1 Asia Pacific Transdermal Patch Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Transdermal Patch Sales by Region (2020-2031)
3.6.3 Asia Pacific Transdermal Patch Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Transdermal Patch Market Facts & Figures by Country
3.7.1 Latin America Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Transdermal Patch Sales by Country (2020-2031)
3.7.3 Latin America Transdermal Patch Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Transdermal Patch Sales by Country (2020-2031)
3.8.3 Middle East and Africa Transdermal Patch Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transdermal Patch Sales by Type (2020-2031)
4.1.1 Global Transdermal Patch Sales by Type (2020-2025)
4.1.2 Global Transdermal Patch Sales by Type (2026-2031)
4.1.3 Global Transdermal Patch Sales Market Share by Type (2020-2031)
4.2 Global Transdermal Patch Revenue by Type (2020-2031)
4.2.1 Global Transdermal Patch Revenue by Type (2020-2025)
4.2.2 Global Transdermal Patch Revenue by Type (2026-2031)
4.2.3 Global Transdermal Patch Revenue Market Share by Type (2020-2031)
4.3 Global Transdermal Patch Price by Type (2020-2031)
5 Segment by Application
5.1 Global Transdermal Patch Sales by Application (2020-2031)
5.1.1 Global Transdermal Patch Sales by Application (2020-2025)
5.1.2 Global Transdermal Patch Sales by Application (2026-2031)
5.1.3 Global Transdermal Patch Sales Market Share by Application (2020-2031)
5.2 Global Transdermal Patch Revenue by Application (2020-2031)
5.2.1 Global Transdermal Patch Revenue by Application (2020-2025)
5.2.2 Global Transdermal Patch Revenue by Application (2026-2031)
5.2.3 Global Transdermal Patch Revenue Market Share by Application (2020-2031)
5.3 Global Transdermal Patch Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Company Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson & Johnson Transdermal Patch Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis Transdermal Patch Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 UCB Pharma
6.4.1 UCB Pharma Company Information
6.4.2 UCB Pharma Description and Business Overview
6.4.3 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.4.4 UCB Pharma Transdermal Patch Product Portfolio
6.4.5 UCB Pharma Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Company Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan Transdermal Patch Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Company Information
6.6.2 Teva Pharmaceutical Description and Business Overview
6.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharmaceutical Transdermal Patch Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.7 Nitto Denko
6.7.1 Nitto Denko Company Information
6.7.2 Nitto Denko Description and Business Overview
6.7.3 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Nitto Denko Transdermal Patch Product Portfolio
6.7.5 Nitto Denko Recent Developments/Updates
6.8 Grünenthal
6.8.1 Grünenthal Company Information
6.8.2 Grünenthal Description and Business Overview
6.8.3 Grünenthal Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Grünenthal Transdermal Patch Product Portfolio
6.8.5 Grünenthal Recent Developments/Updates
6.9 IBSA Group
6.9.1 IBSA Group Company Information
6.9.2 IBSA Group Description and Business Overview
6.9.3 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.9.4 IBSA Group Transdermal Patch Product Portfolio
6.9.5 IBSA Group Recent Developments/Updates
6.10 GSK
6.10.1 GSK Company Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GSK Transdermal Patch Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Luye Pharma Group
6.11.1 Luye Pharma Group Company Information
6.11.2 Luye Pharma Group Description and Business Overview
6.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Luye Pharma Group Transdermal Patch Product Portfolio
6.11.5 Luye Pharma Group Recent Developments/Updates
6.12 Pfizer
6.12.1 Pfizer Company Information
6.12.2 Pfizer Description and Business Overview
6.12.3 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Pfizer Transdermal Patch Product Portfolio
6.12.5 Pfizer Recent Developments/Updates
6.13 Chattem
6.13.1 Chattem Company Information
6.13.2 Chattem Description and Business Overview
6.13.3 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Chattem Transdermal Patch Product Portfolio
6.13.5 Chattem Recent Developments/Updates
6.14 Dr Reddy’s Laboratories
6.14.1 Dr Reddy’s Laboratories Company Information
6.14.2 Dr Reddy’s Laboratories Description and Business Overview
6.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Dr Reddy’s Laboratories Transdermal Patch Product Portfolio
6.14.5 Dr Reddy’s Laboratories Recent Developments/Updates
6.15 Bayer
6.15.1 Bayer Company Information
6.15.2 Bayer Description and Business Overview
6.15.3 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Bayer Transdermal Patch Product Portfolio
6.15.5 Bayer Recent Developments/Updates
6.16 Mundipharma
6.16.1 Mundipharma Company Information
6.16.2 Mundipharma Description and Business Overview
6.16.3 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Mundipharma Transdermal Patch Product Portfolio
6.16.5 Mundipharma Recent Developments/Updates
6.17 Endo International
6.17.1 Endo International Company Information
6.17.2 Endo International Description and Business Overview
6.17.3 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Endo International Transdermal Patch Product Portfolio
6.17.5 Endo International Recent Developments/Updates
6.18 Beijing Tide Pharmaceutical
6.18.1 Beijing Tide Pharmaceutical Company Information
6.18.2 Beijing Tide Pharmaceutical Description and Business Overview
6.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Portfolio
6.18.5 Beijing Tide Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal Patch Industry Chain Analysis
7.2 Transdermal Patch Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal Patch Production Mode & Process Analysis
7.4 Transdermal Patch Sales and Marketing
7.4.1 Transdermal Patch Sales Channels
7.4.2 Transdermal Patch Distributors
7.5 Transdermal Patch Customer Analysis
8 Transdermal Patch Market Dynamics
8.1 Transdermal Patch Industry Trends
8.2 Transdermal Patch Market Drivers
8.3 Transdermal Patch Market Challenges
8.4 Transdermal Patch Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Transdermal Patch Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Transdermal Patch Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Transdermal Patch Market Competitive Situation by Manufacturers in 2024
Table 4. Global Transdermal Patch Sales (M Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Transdermal Patch Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Transdermal Patch Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Transdermal Patch Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Transdermal Patch Average Price (USD/Pc) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Transdermal Patch, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Transdermal Patch, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Transdermal Patch, Product Type & Application
Table 12. Global Key Manufacturers of Transdermal Patch, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Patch as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Transdermal Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Transdermal Patch Sales by Region (2020-2025) & (M Pcs)
Table 18. Global Transdermal Patch Sales Market Share by Region (2020-2025)
Table 19. Global Transdermal Patch Sales by Region (2026-2031) & (M Pcs)
Table 20. Global Transdermal Patch Sales Market Share by Region (2026-2031)
Table 21. Global Transdermal Patch Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Transdermal Patch Revenue Market Share by Region (2020-2025)
Table 23. Global Transdermal Patch Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Transdermal Patch Revenue Market Share by Region (2026-2031)
Table 25. North America Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Transdermal Patch Sales by Country (2020-2025) & (M Pcs)
Table 27. North America Transdermal Patch Sales by Country (2026-2031) & (M Pcs)
Table 28. North America Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Transdermal Patch Sales by Country (2020-2025) & (M Pcs)
Table 32. Europe Transdermal Patch Sales by Country (2026-2031) & (M Pcs)
Table 33. Europe Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Transdermal Patch Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Transdermal Patch Sales by Region (2020-2025) & (M Pcs)
Table 37. Asia Pacific Transdermal Patch Sales by Region (2026-2031) & (M Pcs)
Table 38. Asia Pacific Transdermal Patch Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Transdermal Patch Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Transdermal Patch Sales by Country (2020-2025) & (M Pcs)
Table 42. Latin America Transdermal Patch Sales by Country (2026-2031) & (M Pcs)
Table 43. Latin America Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Transdermal Patch Sales by Country (2020-2025) & (M Pcs)
Table 47. Middle East and Africa Transdermal Patch Sales by Country (2026-2031) & (M Pcs)
Table 48. Middle East and Africa Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Transdermal Patch Sales (M Pcs) by Type (2020-2025)
Table 51. Global Transdermal Patch Sales (M Pcs) by Type (2026-2031)
Table 52. Global Transdermal Patch Sales Market Share by Type (2020-2025)
Table 53. Global Transdermal Patch Sales Market Share by Type (2026-2031)
Table 54. Global Transdermal Patch Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Transdermal Patch Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Transdermal Patch Revenue Market Share by Type (2020-2025)
Table 57. Global Transdermal Patch Revenue Market Share by Type (2026-2031)
Table 58. Global Transdermal Patch Price (USD/Pc) by Type (2020-2025)
Table 59. Global Transdermal Patch Price (USD/Pc) by Type (2026-2031)
Table 60. Global Transdermal Patch Sales (M Pcs) by Application (2020-2025)
Table 61. Global Transdermal Patch Sales (M Pcs) by Application (2026-2031)
Table 62. Global Transdermal Patch Sales Market Share by Application (2020-2025)
Table 63. Global Transdermal Patch Sales Market Share by Application (2026-2031)
Table 64. Global Transdermal Patch Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Transdermal Patch Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Transdermal Patch Revenue Market Share by Application (2020-2025)
Table 67. Global Transdermal Patch Revenue Market Share by Application (2026-2031)
Table 68. Global Transdermal Patch Price (USD/Pc) by Application (2020-2025)
Table 69. Global Transdermal Patch Price (USD/Pc) by Application (2026-2031)
Table 70. Hisamitsu Pharmaceutical Company Information
Table 71. Hisamitsu Pharmaceutical Description and Business Overview
Table 72. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 73. Hisamitsu Pharmaceutical Transdermal Patch Product
Table 74. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 75. Johnson & Johnson Company Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 78. Johnson & Johnson Transdermal Patch Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 83. Novartis Transdermal Patch Product
Table 84. Novartis Recent Developments/Updates
Table 85. UCB Pharma Company Information
Table 86. UCB Pharma Description and Business Overview
Table 87. UCB Pharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 88. UCB Pharma Transdermal Patch Product
Table 89. UCB Pharma Recent Developments/Updates
Table 90. Mylan Company Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 93. Mylan Transdermal Patch Product
Table 94. Mylan Recent Developments/Updates
Table 95. Teva Pharmaceutical Company Information
Table 96. Teva Pharmaceutical Description and Business Overview
Table 97. Teva Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 98. Teva Pharmaceutical Transdermal Patch Product
Table 99. Teva Pharmaceutical Recent Developments/Updates
Table 100. Nitto Denko Company Information
Table 101. Nitto Denko Description and Business Overview
Table 102. Nitto Denko Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 103. Nitto Denko Transdermal Patch Product
Table 104. Nitto Denko Recent Developments/Updates
Table 105. Grünenthal Company Information
Table 106. Grünenthal Description and Business Overview
Table 107. Grünenthal Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 108. Grünenthal Transdermal Patch Product
Table 109. Grünenthal Recent Developments/Updates
Table 110. IBSA Group Company Information
Table 111. IBSA Group Description and Business Overview
Table 112. IBSA Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 113. IBSA Group Transdermal Patch Product
Table 114. IBSA Group Recent Developments/Updates
Table 115. GSK Company Information
Table 116. GSK Description and Business Overview
Table 117. GSK Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 118. GSK Transdermal Patch Product
Table 119. GSK Recent Developments/Updates
Table 120. Luye Pharma Group Company Information
Table 121. Luye Pharma Group Description and Business Overview
Table 122. Luye Pharma Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 123. Luye Pharma Group Transdermal Patch Product
Table 124. Luye Pharma Group Recent Developments/Updates
Table 125. Pfizer Company Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 128. Pfizer Transdermal Patch Product
Table 129. Pfizer Recent Developments/Updates
Table 130. Chattem Company Information
Table 131. Chattem Description and Business Overview
Table 132. Chattem Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 133. Chattem Transdermal Patch Product
Table 134. Chattem Recent Developments/Updates
Table 135. Dr Reddy’s Laboratories Company Information
Table 136. Dr Reddy’s Laboratories Description and Business Overview
Table 137. Dr Reddy’s Laboratories Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 138. Dr Reddy’s Laboratories Transdermal Patch Product
Table 139. Dr Reddy’s Laboratories Recent Developments/Updates
Table 140. Bayer Company Information
Table 141. Bayer Description and Business Overview
Table 142. Bayer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 143. Bayer Transdermal Patch Product
Table 144. Bayer Recent Developments/Updates
Table 145. Mundipharma Company Information
Table 146. Mundipharma Description and Business Overview
Table 147. Mundipharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 148. Mundipharma Transdermal Patch Product
Table 149. Mundipharma Recent Developments/Updates
Table 150. Endo International Company Information
Table 151. Endo International Description and Business Overview
Table 152. Endo International Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 153. Endo International Transdermal Patch Product
Table 154. Endo International Recent Developments/Updates
Table 155. Beijing Tide Pharmaceutical Company Information
Table 156. Beijing Tide Pharmaceutical Description and Business Overview
Table 157. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 158. Beijing Tide Pharmaceutical Transdermal Patch Product
Table 159. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Transdermal Patch Distributors List
Table 163. Transdermal Patch Customers List
Table 164. Transdermal Patch Market Trends
Table 165. Transdermal Patch Market Drivers
Table 166. Transdermal Patch Market Challenges
Table 167. Transdermal Patch Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Transdermal Patch
Figure 2. Global Transdermal Patch Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Transdermal Patch Market Share by Type: 2024 & 2031
Figure 4. Methyl Salicylate-based Patch Product Picture
Figure 5. Rivastigmine Transdermal Patch Product Picture
Figure 6. Fentanyl Transdermal Patch Product Picture
Figure 7. Lidocaine Patch Product Picture
Figure 8. Diclofenac Patch Product Picture
Figure 9. Nicotine Transdermal Patch Product Picture
Figure 10. Others Product Picture
Figure 11. Global Transdermal Patch Market Value by Application (2020-2031) & (US$ Million)
Figure 12. Global Transdermal Patch Market Share by Application: 2024 & 2031
Figure 13. Rx Channel
Figure 14. OTC Channel
Figure 15. Global Transdermal Patch Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Transdermal Patch Market Size (2020-2031) & (US$ Million)
Figure 17. Global Transdermal Patch Sales (2020-2031) & (M Pcs)
Figure 18. Global Transdermal Patch Average Price (USD/Pc) & (2020-2031)
Figure 19. Transdermal Patch Report Years Considered
Figure 20. Transdermal Patch Sales Share by Manufacturers in 2024
Figure 21. Global Transdermal Patch Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Transdermal Patch Players: Market Share by Revenue in Transdermal Patch in 2024
Figure 23. Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Transdermal Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Transdermal Patch Sales Market Share by Country (2020-2031)
Figure 26. North America Transdermal Patch Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Transdermal Patch Sales Market Share by Country (2020-2031)
Figure 30. Europe Transdermal Patch Revenue Market Share by Country (2020-2031)
Figure 31. Germany Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Transdermal Patch Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Transdermal Patch Revenue Market Share by Region (2020-2031)
Figure 38. China Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Transdermal Patch Sales Market Share by Country (2020-2031)
Figure 48. Latin America Transdermal Patch Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Transdermal Patch Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Transdermal Patch Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Transdermal Patch by Type (2020-2031)
Figure 58. Global Revenue Market Share of Transdermal Patch by Type (2020-2031)
Figure 59. Global Transdermal Patch Price (USD/Pc) by Type (2020-2031)
Figure 60. Global Sales Market Share of Transdermal Patch by Application (2020-2031)
Figure 61. Global Revenue Market Share of Transdermal Patch by Application (2020-2031)
Figure 62. Global Transdermal Patch Price (USD/Pc) by Application (2020-2031)
Figure 63. Transdermal Patch Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Transdermal Patch Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Transdermal Patch Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Transdermal Patch Market Competitive Situation by Manufacturers in 2024
Table 4. Global Transdermal Patch Sales (M Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Transdermal Patch Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Transdermal Patch Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Transdermal Patch Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Transdermal Patch Average Price (USD/Pc) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Transdermal Patch, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Transdermal Patch, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Transdermal Patch, Product Type & Application
Table 12. Global Key Manufacturers of Transdermal Patch, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Patch as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Transdermal Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Transdermal Patch Sales by Region (2020-2025) & (M Pcs)
Table 18. Global Transdermal Patch Sales Market Share by Region (2020-2025)
Table 19. Global Transdermal Patch Sales by Region (2026-2031) & (M Pcs)
Table 20. Global Transdermal Patch Sales Market Share by Region (2026-2031)
Table 21. Global Transdermal Patch Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Transdermal Patch Revenue Market Share by Region (2020-2025)
Table 23. Global Transdermal Patch Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Transdermal Patch Revenue Market Share by Region (2026-2031)
Table 25. North America Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Transdermal Patch Sales by Country (2020-2025) & (M Pcs)
Table 27. North America Transdermal Patch Sales by Country (2026-2031) & (M Pcs)
Table 28. North America Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Transdermal Patch Sales by Country (2020-2025) & (M Pcs)
Table 32. Europe Transdermal Patch Sales by Country (2026-2031) & (M Pcs)
Table 33. Europe Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Transdermal Patch Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Transdermal Patch Sales by Region (2020-2025) & (M Pcs)
Table 37. Asia Pacific Transdermal Patch Sales by Region (2026-2031) & (M Pcs)
Table 38. Asia Pacific Transdermal Patch Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Transdermal Patch Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Transdermal Patch Sales by Country (2020-2025) & (M Pcs)
Table 42. Latin America Transdermal Patch Sales by Country (2026-2031) & (M Pcs)
Table 43. Latin America Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Transdermal Patch Sales by Country (2020-2025) & (M Pcs)
Table 47. Middle East and Africa Transdermal Patch Sales by Country (2026-2031) & (M Pcs)
Table 48. Middle East and Africa Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Transdermal Patch Sales (M Pcs) by Type (2020-2025)
Table 51. Global Transdermal Patch Sales (M Pcs) by Type (2026-2031)
Table 52. Global Transdermal Patch Sales Market Share by Type (2020-2025)
Table 53. Global Transdermal Patch Sales Market Share by Type (2026-2031)
Table 54. Global Transdermal Patch Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Transdermal Patch Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Transdermal Patch Revenue Market Share by Type (2020-2025)
Table 57. Global Transdermal Patch Revenue Market Share by Type (2026-2031)
Table 58. Global Transdermal Patch Price (USD/Pc) by Type (2020-2025)
Table 59. Global Transdermal Patch Price (USD/Pc) by Type (2026-2031)
Table 60. Global Transdermal Patch Sales (M Pcs) by Application (2020-2025)
Table 61. Global Transdermal Patch Sales (M Pcs) by Application (2026-2031)
Table 62. Global Transdermal Patch Sales Market Share by Application (2020-2025)
Table 63. Global Transdermal Patch Sales Market Share by Application (2026-2031)
Table 64. Global Transdermal Patch Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Transdermal Patch Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Transdermal Patch Revenue Market Share by Application (2020-2025)
Table 67. Global Transdermal Patch Revenue Market Share by Application (2026-2031)
Table 68. Global Transdermal Patch Price (USD/Pc) by Application (2020-2025)
Table 69. Global Transdermal Patch Price (USD/Pc) by Application (2026-2031)
Table 70. Hisamitsu Pharmaceutical Company Information
Table 71. Hisamitsu Pharmaceutical Description and Business Overview
Table 72. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 73. Hisamitsu Pharmaceutical Transdermal Patch Product
Table 74. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 75. Johnson & Johnson Company Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 78. Johnson & Johnson Transdermal Patch Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 83. Novartis Transdermal Patch Product
Table 84. Novartis Recent Developments/Updates
Table 85. UCB Pharma Company Information
Table 86. UCB Pharma Description and Business Overview
Table 87. UCB Pharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 88. UCB Pharma Transdermal Patch Product
Table 89. UCB Pharma Recent Developments/Updates
Table 90. Mylan Company Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 93. Mylan Transdermal Patch Product
Table 94. Mylan Recent Developments/Updates
Table 95. Teva Pharmaceutical Company Information
Table 96. Teva Pharmaceutical Description and Business Overview
Table 97. Teva Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 98. Teva Pharmaceutical Transdermal Patch Product
Table 99. Teva Pharmaceutical Recent Developments/Updates
Table 100. Nitto Denko Company Information
Table 101. Nitto Denko Description and Business Overview
Table 102. Nitto Denko Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 103. Nitto Denko Transdermal Patch Product
Table 104. Nitto Denko Recent Developments/Updates
Table 105. Grünenthal Company Information
Table 106. Grünenthal Description and Business Overview
Table 107. Grünenthal Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 108. Grünenthal Transdermal Patch Product
Table 109. Grünenthal Recent Developments/Updates
Table 110. IBSA Group Company Information
Table 111. IBSA Group Description and Business Overview
Table 112. IBSA Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 113. IBSA Group Transdermal Patch Product
Table 114. IBSA Group Recent Developments/Updates
Table 115. GSK Company Information
Table 116. GSK Description and Business Overview
Table 117. GSK Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 118. GSK Transdermal Patch Product
Table 119. GSK Recent Developments/Updates
Table 120. Luye Pharma Group Company Information
Table 121. Luye Pharma Group Description and Business Overview
Table 122. Luye Pharma Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 123. Luye Pharma Group Transdermal Patch Product
Table 124. Luye Pharma Group Recent Developments/Updates
Table 125. Pfizer Company Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 128. Pfizer Transdermal Patch Product
Table 129. Pfizer Recent Developments/Updates
Table 130. Chattem Company Information
Table 131. Chattem Description and Business Overview
Table 132. Chattem Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 133. Chattem Transdermal Patch Product
Table 134. Chattem Recent Developments/Updates
Table 135. Dr Reddy’s Laboratories Company Information
Table 136. Dr Reddy’s Laboratories Description and Business Overview
Table 137. Dr Reddy’s Laboratories Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 138. Dr Reddy’s Laboratories Transdermal Patch Product
Table 139. Dr Reddy’s Laboratories Recent Developments/Updates
Table 140. Bayer Company Information
Table 141. Bayer Description and Business Overview
Table 142. Bayer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 143. Bayer Transdermal Patch Product
Table 144. Bayer Recent Developments/Updates
Table 145. Mundipharma Company Information
Table 146. Mundipharma Description and Business Overview
Table 147. Mundipharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 148. Mundipharma Transdermal Patch Product
Table 149. Mundipharma Recent Developments/Updates
Table 150. Endo International Company Information
Table 151. Endo International Description and Business Overview
Table 152. Endo International Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 153. Endo International Transdermal Patch Product
Table 154. Endo International Recent Developments/Updates
Table 155. Beijing Tide Pharmaceutical Company Information
Table 156. Beijing Tide Pharmaceutical Description and Business Overview
Table 157. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 158. Beijing Tide Pharmaceutical Transdermal Patch Product
Table 159. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Transdermal Patch Distributors List
Table 163. Transdermal Patch Customers List
Table 164. Transdermal Patch Market Trends
Table 165. Transdermal Patch Market Drivers
Table 166. Transdermal Patch Market Challenges
Table 167. Transdermal Patch Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Transdermal Patch
Figure 2. Global Transdermal Patch Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Transdermal Patch Market Share by Type: 2024 & 2031
Figure 4. Methyl Salicylate-based Patch Product Picture
Figure 5. Rivastigmine Transdermal Patch Product Picture
Figure 6. Fentanyl Transdermal Patch Product Picture
Figure 7. Lidocaine Patch Product Picture
Figure 8. Diclofenac Patch Product Picture
Figure 9. Nicotine Transdermal Patch Product Picture
Figure 10. Others Product Picture
Figure 11. Global Transdermal Patch Market Value by Application (2020-2031) & (US$ Million)
Figure 12. Global Transdermal Patch Market Share by Application: 2024 & 2031
Figure 13. Rx Channel
Figure 14. OTC Channel
Figure 15. Global Transdermal Patch Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Transdermal Patch Market Size (2020-2031) & (US$ Million)
Figure 17. Global Transdermal Patch Sales (2020-2031) & (M Pcs)
Figure 18. Global Transdermal Patch Average Price (USD/Pc) & (2020-2031)
Figure 19. Transdermal Patch Report Years Considered
Figure 20. Transdermal Patch Sales Share by Manufacturers in 2024
Figure 21. Global Transdermal Patch Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Transdermal Patch Players: Market Share by Revenue in Transdermal Patch in 2024
Figure 23. Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Transdermal Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Transdermal Patch Sales Market Share by Country (2020-2031)
Figure 26. North America Transdermal Patch Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Transdermal Patch Sales Market Share by Country (2020-2031)
Figure 30. Europe Transdermal Patch Revenue Market Share by Country (2020-2031)
Figure 31. Germany Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Transdermal Patch Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Transdermal Patch Revenue Market Share by Region (2020-2031)
Figure 38. China Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Transdermal Patch Sales Market Share by Country (2020-2031)
Figure 48. Latin America Transdermal Patch Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Transdermal Patch Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Transdermal Patch Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Transdermal Patch by Type (2020-2031)
Figure 58. Global Revenue Market Share of Transdermal Patch by Type (2020-2031)
Figure 59. Global Transdermal Patch Price (USD/Pc) by Type (2020-2031)
Figure 60. Global Sales Market Share of Transdermal Patch by Application (2020-2031)
Figure 61. Global Revenue Market Share of Transdermal Patch by Application (2020-2031)
Figure 62. Global Transdermal Patch Price (USD/Pc) by Application (2020-2031)
Figure 63. Transdermal Patch Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232